Aligos Therapeutics (ALGS) EPS (Basic) Growth (1y) (2020 - 2026)
Aligos Therapeutics (ALGS) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -16.29% |
| 10 | Aligos Therapeutics | 70.20 Mn | 39.76 Mn | - | 90.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.59% |
| Mar 31, 2026 | -143.22% |
| Dec 31, 2025 | 84.66% |
| Sep 30, 2025 | 0.95% |
| Jun 30, 2025 | -289.49% |
| Mar 31, 2025 | 191.81% |
| Dec 31, 2024 | -20.85% |
| Sep 30, 2024 | 70.39% |
| Jun 30, 2024 | 107.44% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | 15.33% |
| Sep 30, 2023 | 4.75% |
| Jun 30, 2023 | 6.89% |
| Mar 31, 2023 | 36.15% |
| Dec 31, 2022 | 45.83% |
| Sep 30, 2022 | 44.26% |
| Jun 30, 2022 | 41.08% |
| Mar 31, 2022 | -13.32% |
| Dec 31, 2021 | 72.54% |
| Sep 30, 2021 | 92.90% |